KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Receivables: 2009-2024

Historic Receivables for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $46.9 million.

  • Dynavax Technologies' Receivables fell 2.60% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.1 million, marking a year-over-year increase of 9.42%. This contributed to the annual value of $46.9 million for FY2024, which is 5.33% up from last year.
  • As of FY2024, Dynavax Technologies' Receivables stood at $46.9 million, which was up 5.33% from $44.5 million recorded in FY2023.
  • Dynavax Technologies' 5-year Receivables high stood at $217.1 million for FY2022, and its period low was $22.3 million during FY2020.
  • Over the past 3 years, Dynavax Technologies' median Receivables value was $46.9 million (recorded in 2024), while the average stood at $102.8 million.
  • In the last 5 years, Dynavax Technologies' Receivables skyrocketed by 701.35% in 2021 and then tumbled by 79.49% in 2023.
  • Dynavax Technologies' Receivables (Yearly) stood at $22.3 million in 2020, then spiked by 701.35% to $178.7 million in 2021, then increased by 21.46% to $217.1 million in 2022, then slumped by 79.49% to $44.5 million in 2023, then grew by 5.33% to $46.9 million in 2024.